Universal Ibogaine Inc. Retains Co-Founder Shayne Nyquvest as Financial Markets Advisor

Universal Ibogaine Inc (TSX-V:IBO) told investors that it had retained the services of Shayne Nyquvest in a consulting role as a capital markets adviser.

Nyquvest, co-founder of the company, has extensive experience in the financial markets, with over 40 years of involvement in assisting strategic corporate fundraising activities, in the mining, cannabis and other industries. emerging industries, the life sciences group said.

He was the former Executive Vice President of investment banking firm Mackie Research Capital, where he worked from June 2015 to July 2018 and was a founding member of the Canaccord Genuity Group, where he worked as a Senior Advisor in investment from 1993 to 2013.

READ: Universal Ibogaine plans to resume operations after Kelburn recovery center flood

“We are delighted that Shayne has recommitted to our strategic business development goals,” company CEO Nick Karos said in a statement. Activities.”

Nyquvest co-founded Universal Ibogaine in early 2018 after firsthand seeing the transformational effects and potential of ibogaine and was involved in the company’s early development through mid-2021.

The company said Nyquvest’s vision is to see this innovative herbal treatment embraced by the mainstream medical community as a solution to help break the epidemic of opioids and other addictions.

“We continue to advance our planned clinical trial application from Health Canada for the use of ibogaine in opioid use disorder and expect to provide additional updates on this in a near future,” Karos added.

Universal Ibogaine’s mission is to demonstrate the safety and efficacy of its ibogaine-based detoxification protocol through a planned Canadian clinical trial (focused on opioid use disorder) and ultimately to use this protocol worldwide through planned future licensing agreements.

The company is simultaneously developing a state-of-the-art holistic addiction treatment protocol at its Kelburn recovery center which, when combined with the planned ibogaine detox protocol, aims to revolutionize the way we treat addiction and significantly improve the lives of individuals and families affected by addiction.

Contact the author at [email protected]